Journal of Alzheimers Disease & Parkinsonism
Open Access

Disruption of proteostatic networks in Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

David R Borchelt and Guilian Xu

HTML PDF Digital File

A carboxylated Zn-phthalocyanine inhibits the fibril formation of Alzheimer�s amyloid β peptide

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Atsushi Nagai, Abdullah Md Sheikh, Shatera Tabassum, Shozo Yano, Takafumi Ikeue, Makoto Handa

HTML PDF Digital File

Astrocytic contribution to deficient Ca2+ signalling and oxidative stress mediated by TRPV4 channels in Aβ40-induced hippocampal cell death

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Ji Zhong Bai and Janusz Lipski

HTML PDF Digital File

Common risk factors for Alzheimer�s disease and vascular dementia

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Ken Nagata, Takashi Yamazaki and Daiki Takano

HTML PDF Digital File

Copper dysfunction in Alzheimer�s disease (AD): Alleles in ATP7B gene and increased levels of non-ceruloplasmin-copper raise the risk for AD

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Rosanna Squitti

HTML PDF Digital File

Body mass index and risk of future dementia over two decades in two million people

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Qizilbash Nawab, Gregson J, Johnson M, Pearce N, Douglas I, Wing K, Evans S J W and Pocock S

HTML PDF Digital File

Traumatic Brain Injury (TBI) as a missed cause of Dementia

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Anne Felicia Ambrose

HTML PDF Digital File

Addressing nutritional requirements in early Alzheimer�s disease: What, why and when?

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Laus Broersen

HTML PDF Digital File

Neurochemical dementia diagnostics for the early diagnosis of Alzheimer�s disease: State-of-theart and the perspectives

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Piotr Lewczuk

HTML PDF Digital File

Altered copper metabolism as a theranostic biomarker in neurodegeneration

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Fangyu Peng

HTML PDF Digital File

The Aβ oligomer count in CSF is a useful biomarker for Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Dieter Willbold

HTML PDF Digital File

CSF Anti-Aβ autoantibodies as novel biomarker for cerebral amyloid angiopathy-related inflammation: Implications for amyloid-related imaging abnormalities (ARIA) during passive immunization in Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Fabrizio Piazza, S M Greenberg, A Lleo Bisa, J F Vazquez Costa, R Nitrini, A Kakita, Y Hagiwara, G Giaccone, G Boncoraglio, M Glatzel, C Marini1, A Uncini, S Cirillo, F Tagliavini, C Ferrarese and J C DiFrancesco

HTML PDF Digital File

Cerebral blood flow by means of xenon-enhanced computed tomography: From trans-axial to surface quantitative images

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Shigeru Sase

HTML PDF Digital File

PZP: A novel biomarker for early Alzheimer�s disease?

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Diana A T Nijholt

HTML PDF Digital File

Unexpected brain MRI abnormalities in aging research studies

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Howard A Rowley

HTML PDF Digital File

Tau PET imaging: New insight into early diagnosis of tauopathy

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Naruhiko Sahara

HTML PDF Digital File

Early dysfunctions preceding neurodegeneration in synucleinopathy

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Elvira De Leonibus

HTML PDF Digital File

Alzheimer disease and neuroplasticity: New approaches and new targets

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Tayfun Uzbay

HTML PDF Digital File

Rescue of TGF-b1 signalling as a new strategy for neuroprotection in AD: Role of antidepressant drugs

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Filippo Caraci

HTML PDF Digital File

Stealth adapted viruses, alternative cellular energy (ACE) pathway and Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

W John Martin

HTML PDF Digital File

The role of apoptotic mechanisms in the pathophysiology of Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Rona K Graham

HTML PDF Digital File

Amyloid-β precursor protein presence on the neuron surface is required for the iron pore ferroportin to efflux iron

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

James A Duce

HTML PDF Digital File

P53 family pathway activation in microglia; implications for neurodegeneration

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Jennifer Pocock

HTML PDF Digital File

Optogenetic investigation of brain network dysfunction in Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Mondragon-Rodriguez Siddhartha

HTML PDF Digital File

Metabolic syndrome, neuroinflammation and cognitive impairment: State of the art and results from a second level outpatient clinic in Italy

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Calsolaro Valeria, Pasqualetti Giuseppe, Tognini Sara, Polini Antonio, Cottone Silvia, Bini Giacomo1, Atteo Elisabetta, De Feo Paola1, Meucci Giuseppe and Monzani Fabio

HTML PDF Digital File

Insulin resistance: Risk factor of dementia

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Natalie Rasgon

HTML PDF Digital File

A prophylactic daily program for dementia

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Toru Itakura and Yoshihito Owai

HTML PDF Digital File

Neurochemical dementia diagnostics - Interlaboratory variation of analysis, reference ranges and interpretations in the European CSF Survey of INSTAND

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Hansotto Reiber, Peter Lange and Inga Zerr

HTML PDF Digital File

Genetic modifiers of repeat expansions in C9ORF72

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Markavan Blitterswijk

HTML PDF Digital File

Dementia in children and young adults with Niemann-Pick disease type C (NPC)

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Jacqueline Imrie

HTML PDF Digital File

Managing mood and behaviors in long-term care facilities in the United States

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Eric G Tangalos

HTML PDF Digital File

KEEPS cognitive and affective study: Effects of estrogen on cognition and mood in recently post menopausal Women

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Sanjay Asthana, Carey Gleason, Maritza Dowling and Whitney Wharton

HTML PDF Digital File

Different types of soy products and their possible benefit and risk associated with dementia in China and Indonesia

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Eef Hogervorst

HTML PDF Digital File

Vitamin B12 deficiency and cognitive impairment: Re-visiting an old acquaintance

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Belinda Vicioso

HTML PDF Digital File

Indicators of quality of care for patients with dementia in the acute care setting

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Melinda Martin Khan

HTML PDF Digital File

A theoretical framework for environmental design intervention to support neurodegenerative disease management

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Attila Lawrence

HTML PDF Digital File

Latent Herpes virus infection cognitive deterioration and dementia

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Federico Licastro

HTML PDF Digital File

Long-term ongoing structured support in early stage of dementia: PER-model

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Annika Kjallman Alm

HTML PDF Digital File

Black and minority ethnic communities and dementia: Where are we now?

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Truswell David

HTML PDF Digital File

Dementia and public health: Promise, pitfalls and progress

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Melinda Martin Khan, Travers C, Halliday L and Lie D

HTML PDF Digital File

The frequency of cognitive impairment and dementia one year after ischemic stroke in Bulgarian patients

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Neli Petrova, S Mehrabian, M Raycheva and L Traykov

HTML PDF Digital File

What are the prospects of slowing the progression of Alzheimer�s disease?

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Alan M Palmer

HTML PDF Digital File

Evaluation of remediation of neuropsychological deficits in diagnosed dementia population through cognitive therapy/training

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Barbara C Fisher

HTML PDF Digital File

Amylin: What might be its role in Alzheimer�s disease and how could this affect therapy?

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Charles De Carli

HTML PDF Digital File

Neuropsychiatric symptoms in Alzheimer�s disease: Contradictory interpretations between caregiver report and clinician impression

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Florindo Stella

HTML PDF Digital File

Insulin-like growth factor II reverses memory and synaptic impairments in APP transgenic mice

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Ana Gracia Osta, Garcia-Barroso C, Ugarte A, Oyarazabal J and Mar Cuadrado-Tejedor

HTML PDF Digital File

Epigenetic approaches for the treatment of Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Mar Cuadrado-Tejedor, Carolina Garcia-Barroso, Julen Oyarzabal and Ana Garcia-Osta

HTML PDF Digital File

Contributions of translational behavioral neuroscience to the advanced diagnostic and therapeutic approaches towards dementia

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Lydia Gimenez Llort

HTML PDF Digital File

Discovery and development of novel functionally-selective S1R ligands as potential Alzheimer�s diseasemodifying therapeutics

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

John A Schetz

HTML PDF Digital File

Pyrroloquinoline quinone nutritional status revert synaptosomal mitochondrial dysfunction and behavioral alterations in a transgenic rat model of Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Laura Morelli

HTML PDF Digital File

New cellular models for drug discovery in Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Jordan L Holtzman

HTML PDF Digital File

Involvement of PKR in Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

Jacques Hugon, Julien Dumurgier, Fran�ois Mouton-Liger, Pauline Lapalus, Magali Prevot, Sandrine Indart, Jean Louis Laplanche and Claire Paquet

HTML PDF Digital File

Development of polysorbate-80 coated galantamine nanorticles to treat Alzheimer�s disease

J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.006

C Vijaya Raghavan, N Tamilselvan, K Balakumar, Siram Karthik

HTML PDF Digital File